Cholesterol Lowering Drugs Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027
The global cholesterol lowering drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). In general, cholesterol is considered to be fundamentally required by the body, however, more than 240 mg/dl is termed as high cholesterol. A total cholesterol of 200 mg/dl or lower is acceptable, and 200–240 mg/dl is considered borderline high. Such excessive level of cholesterol in the blood is known as hypercholesterolemia. High cholesterol may be a result of imbalanced diet, genetic diseases, obesity, or other diseases such as diabetes and an underactive thyroid. For instance, as per the International Diabetes Federation (IDF), the total adult population in the US suffering from diabetes was 31 million in 2019 while in Canada, it was 2.8 million. Moreover, there were around 189,000 mortalities due to diabetes in the US in 2019, which represents one of the highest numbers of mortalities all around the globe. Thus, the increased prevalence of diabetes as a result of high cholesterol is primarily driving the demand for cholesterol lowering drugs.
To Request a Sample of our Report on Cholesterol
Lowering Drugs Market:
https://www.omrglobal.com/request-sample/cholesterol-lowering-drugs-market
Apart from the common factors
such as sedentary routines, increase in the consumption of saturated and
trans-fat is also responsible for elevated levels of cholestrol all over the
globe. The global cholesterol lowering drugs market is further likely to grow
owing to the emergence of new drug classes, more effective therapies such as
PCSK9 inhibitors, bempedoic acid, and the novel drugs in their pipeline phase. Although
the major side effects of statins causing rhabdomyolysis as well as the easy
accessibility to generic drugs of leading brands are projected to restrain the
market growth during the forecast period.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
·
By Drug Class
·
By Indication
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
AstraZeneca plc, Sanofi S.A., and Merck & Co., Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Cholesterol Lowering Drugs Market is Available @ https://www.omrglobal.com/industry-reports/cholesterol-lowering-drugs-market
Global Cholesterol Lowering Drugs Market Report by
Segment
By Drug Class
• Statins & Combination
• PCSK9 Inhibitor
• Bile Acid Sequestrants
• Fibrates
• Cholesterol Absorption Inhibitors
• Others
By Indication
• Hypercholesterolemia
• Coronary Artery Inhibitors
• Higher Triglycerides
Global Cholesterol Lowering Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment